109 related articles for article (PubMed ID: 17912229)
1. A practical approach to immune monitoring in kidney transplantation.
Rodrigo E; Arias M
Minerva Urol Nefrol; 2007 Sep; 59(3):337-52. PubMed ID: 17912229
[TBL] [Abstract][Full Text] [Related]
2. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
3. Modified ELISPOT technique--highly significant inverse correlation of post-Tx donor-reactive IFNgamma-producing cell frequencies with 6 and 12 months graft function in kidney transplant recipients.
Näther BJ; Nickel P; Bold G; Presber F; Schönemann C; Pratschke J; Volk HD; Reinke P
Transpl Immunol; 2006 Nov; 16(3-4):232-7. PubMed ID: 17138059
[TBL] [Abstract][Full Text] [Related]
4. Immune monitoring after kidney transplantation.
Gerrits JH; Weimar W; Van Besouw NM
Minerva Urol Nefrol; 2007 Sep; 59(3):367-72. PubMed ID: 17912231
[TBL] [Abstract][Full Text] [Related]
5. Pre-transplant donor-specific T-cell alloreactivity is strongly associated with early acute cellular rejection in kidney transplant recipients not receiving T-cell depleting induction therapy.
Crespo E; Lucia M; Cruzado JM; Luque S; Melilli E; Manonelles A; Lloberas N; Torras J; Grinyó JM; Bestard O
PLoS One; 2015; 10(2):e0117618. PubMed ID: 25689405
[TBL] [Abstract][Full Text] [Related]
6. Immunological monitoring after organ transplantation: potential role of soluble CD30 blood level measurement.
Truong DQ; Darwish AA; Gras J; Wieërs G; Cornet A; Robert A; Mourad M; Malaise J; de Ville de Goyet J; Reding R; Latinne D
Transpl Immunol; 2007 Jun; 17(4):283-7. PubMed ID: 17493532
[TBL] [Abstract][Full Text] [Related]
7. A pilot study of immunosuppression minimization after pancreas-kidney transplantation utilizing thymoglobulin induction and sirolimus maintenance therapy.
Knight RJ; Kerman RH; McKissick E; Lawless A; Podder H; Katz S; Van Buren CT; Kahan BD
Transplant Proc; 2005 Oct; 37(8):3538-41. PubMed ID: 16298653
[TBL] [Abstract][Full Text] [Related]
8. Development of tolerogenic strategies in the clinic.
Knechtle SJ
Philos Trans R Soc Lond B Biol Sci; 2005 Sep; 360(1461):1739-46. PubMed ID: 16147538
[TBL] [Abstract][Full Text] [Related]
9. Post-transplant monitoring of soluble CD30 level as predictor of graft outcome: a single center experience from China.
Wang D; Wu W; Yang S; Wang Q; Tan J
Transpl Immunol; 2012 Dec; 27(4):146-50. PubMed ID: 23079227
[TBL] [Abstract][Full Text] [Related]
10. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
[TBL] [Abstract][Full Text] [Related]
11. Tolerance assays: measuring the unknown.
Newell KA; Larsen CP
Transplantation; 2006 Jun; 81(11):1503-9. PubMed ID: 16770237
[TBL] [Abstract][Full Text] [Related]
12. Monitoring tolerance after human liver transplantation.
Wieërs G; Gras J; Bourdeaux C; Truong DQ; Latinne D; Reding R
Transpl Immunol; 2007 Feb; 17(2):83-93. PubMed ID: 17306738
[TBL] [Abstract][Full Text] [Related]
13. Calculated withdrawal of low-dose immunosuppression based on a detailed immunological monitoring after kidney transplantation between monocygotic twins.
Hüser N; Matevossian E; Schmidbauer P; Assfalg V; Scherberich JE; Stangl M; Holzmann B; Friess H; Laschinger M
Transpl Immunol; 2009 Dec; 22(1-2):38-43. PubMed ID: 19766188
[TBL] [Abstract][Full Text] [Related]
14. Graft survival and immune regulation of pancreas allograft recipients induced with thymoglobulin, sirolimus, and cyclosporine.
Knight RJ; Kerman RH; Podder H; Katz SM; Van Buren CT; Kahan BD
Transplant Proc; 2005 Mar; 37(2):1280-2. PubMed ID: 15848695
[TBL] [Abstract][Full Text] [Related]
15. Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches.
Gerrits JH; van de Wetering J; Postma S; Drabbels JJ; Vaessen LM; IJzermans JN; Rischen J; Claas FH; Weimar W; van Besouw NM
Nephrol Dial Transplant; 2007 Feb; 22(2):353-61. PubMed ID: 17124279
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of T-cell monitoring assays in kidney transplantation.
Nickel P; Bestard O; Volk HD; Reinke P
Curr Opin Organ Transplant; 2009 Aug; 14(4):426-31. PubMed ID: 19417657
[TBL] [Abstract][Full Text] [Related]
17. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
Trzonkowski P; Zilvetti M; Friend P; Wood KJ
Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
[TBL] [Abstract][Full Text] [Related]
18. Different reconstitution of peripheral blood lymphocytes and dendritic cells in liver and kidney transplant patients.
Rondelli D; Abbasian J; Arpinati M; Panaro F; Porubsky M; Manzelli A; Oberholzer J; Benedetti E; Testa G
Transplant Proc; 2005; 37(1):49-50. PubMed ID: 15808543
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers to assess donor-reactive T-cell responses in kidney transplant patients.
Crespo E; Bestard O
Clin Biochem; 2016 Mar; 49(4-5):329-37. PubMed ID: 26279496
[TBL] [Abstract][Full Text] [Related]
20. Preceeding the rejection: in search for a comprehensive post-transplant immune monitoring platform.
Israeli M; Yussim A; Mor E; Sredni B; Klein T
Transpl Immunol; 2007 Jul; 18(1):7-12. PubMed ID: 17584596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
